"No Evidence" Of Higher Risk Of Blood Clots From Vaccine: AstraZeneca | Read
UK-based pharmaceutical company AstraZeneca insisted on Friday its coronavirus vaccine was safe, after some countries suspended its use in response to concerns about a potential link to blood clots. "An analysis of our safety data of more than 10 million records has shown no evidence of an increased risk of pulmonary embolism or deep vein thrombosis in any defined age group, gender, batch or in any particular country" from the jab, a company spokesperson said.
